To investigate the relationship between CAFs and the malignance phenotype, we first studied the expression of α-SMA (a myoepithelial cell marker) and Ki67 (a marker of proliferating cells) in tumor and non-tumor tissues obtained from BC patients. The gene discussed is ACTA1; the disease is breast cancer.